H-1B Filings
56
DOL labor condition applications on file
Manufacturing DE
AstraZeneca Pharmaceuticals LP: Workforce Profile
Federal-records workforce intelligence for AstraZeneca Pharmaceuticals LP (DE): H-1B labor condition applications, OSHA injury and illness records, and WARN Act mass-layoff disclosures, fused into one transparent profile.
Median H-1B Salary
$175,000
Across 52 disclosed positions
Layoff Stability
0 WARN notices
Clean record in state workforce filings
The record at a glance
AstraZeneca Pharmaceuticals LP carries 56 H-1B wage filings on record, a $175,000 median wage (above the $120,000 national median) and no WARN layoff notices on file.
- 56
- H-1B filings
- $175,000
- median H-1B wage
- 0
- WARN notices
Every figure is drawn directly from a public federal disclosure (DOL H-1B Labor Condition Applications, OSHA injury logs, and state WARN Act notices), never from private reviews or self-reported metrics.
Where AstraZeneca Pharmaceuticals LP's H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$175,000 Top 17% higher than 83% of 178,031 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · May 2026
Government Data Summary
| Field | Value | Source |
|---|---|---|
| Employer Name | AstraZeneca Pharmaceuticals LP | DOL OFLC / OSHA / WARN |
| Industry | Manufacturing | NAICS / DOL |
| State | DE | U.S. Federal Records |
| H-1B Filings | 56 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $175,000 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | Not in OSHA dataset | OSHA ITA |
| OSHA DART Rate | Not reported | OSHA ITA Establishment Records |
| WARN Layoff Notices | No WARN notices | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
Compiled from public records. Federal employer data is reported per OFFCP / EEOC compliance frameworks; values reflect the most recent disclosure period available.
H-1B Salary Data
| Job Title | Median |
|---|---|
| Strategic Project Lead, IBEX | $321,014 |
| Global Head, Marketing - Eplontersen | $314,720 |
| Senior Medical Affairs Leader, Vaccines & Infectious Disease | $311,233 |
| Senior Medical Affairs Leader, Vaccines & Infectious Disease | $311,233 |
| Director, Lifecycle and Pipeline, Oncology | $260,882 |
| Regulatory Affairs Director “ Oncology | $225,000 |
| Director, Business Planning and Operations | $220,160 |
| Associate Director – Oncology Safety Pathology | $220,000 |
| Business Insights Director | $215,095 |
| Statistical Science Director (GPS) | $205,197 |
| Statistical Science Director (GPS) | $205,197 |
| Associate Director, Analytics US Oncology | $205,000 |
| US Forecasting Director | $200,096 |
| Regulatory Affairs Portfolio Director | $200,000 |
| A&R IT Product Lead | $190,965 |
| Enterprise Regulatory Vault Product Owner | $187,200 |
| Director, Tech. Axial Product Lead Secondary Distribution | $185,329 |
| Director, Commercial IT - Platform Engineering | $183,273 |
| Director, Commercial IT - Business Partner, OBU | $182,000 |
| Associate Regulatory Affair Director | $181,709 |
| Statistical Programming Associate Director | $180,814 |
| Associate Director, Patient Safety Scientist | $180,405 |
| Associate Director, Corporate Development | $175,000 |
| Associate Director, Data Management & Operations | $175,000 |
| Associate Director, Data Management & Operations | $175,000 |
| Associate Director, Data Management & Operations | $175,000 |
| Senior Manager, US Oncology Insights & Analytics | $170,000 |
| Senior Manager, Oncology Access Strategy - IO | $168,000 |
| Associate Director, Clinical Pharmacology & Pharmacometrics | $163,000 |
| Senior Scientist, Biologics Engineering | $156,000 |
| Associate Director | $155,948 |
| Senior Scientist, Translational PKPD | $155,250 |
| Associate Director | $155,085 |
| Associate Director, Data Science & AI - Oncology Product | $153,920 |
| Associate Director | $147,000 |
| Senior Statistician II | $143,540 |
| Associate Director - R&D Data & Systems | $142,000 |
| Senior Validation Engineer | $141,963 |
| Senior Scientist, Integrated Bioanalysis | $141,331 |
| Senior Specialist, Programming II | $140,675 |
| Sr. Scientist Translational Pathology Image Analysis & Data | $139,296 |
| Senior Scientist | $133,078 |
| Senior Scientist | $130,869 |
| Senior Scientist | $128,100 |
| Senior Scientist, Proteomics | $121,730 |
| Senior Scientist, Bioscience | $113,000 |
| Scientist, Cancer Biology (Antibody Drug Conjugates) | $111,372 |
| Scientist, Translational Research | $111,324 |
| Senior Scientist | $109,913 |
| Senior Process Engineer - Formulation | $109,433 |
What the Data Says About AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP operating in DE within the Manufacturing sector appears across multiple federal and state datasets that every job seeker, investigative reporter, and compliance researcher should know about. The company has filed 56 H-1B labor condition applications with a median disclosed wage of $175,000. Records here combine U.S. Department of Labor disclosures and state workforce agency filings. Each row on this page is sourced directly from a public government record, not a paid vendor or crowd-sourced review site, so the numbers reflect legally filed disclosures rather than opinion.
AstraZeneca Pharmaceuticals LP does not currently have an OSHA DART rate on file in our dataset, which typically means the employer is either below the size threshold for mandatory injury recordkeeping, operates in an industry with partial OSHA exemptions, or has not yet been captured in the most recent data release. Absence of a safety grade is not by itself a red or green flag, it simply means the most reliable workplace-safety signal we use elsewhere on the site is not available for this employer. Researchers can still cross-reference WARN Act notices, H-1B filings, and state-level labor disclosures for a fuller picture.
No WARN Act mass-layoff notices are currently on file for AstraZeneca Pharmaceuticals LP in the state workforce records we track. That absence is a meaningful positive signal for workforce stability, not a guarantee, since smaller layoffs that fall below WARN thresholds (typically 50 to 500 workers depending on site and state) don't trigger a notice, but still a cleaner record than many peers in the same industry. Cross-reference this profile with the matching industry and metro pages on PlainEmployers to see how AstraZeneca Pharmaceuticals LP benchmarks against nearby employers on wages, safety, and overall workforce stability; every number flows from the same federal and state datasets and refreshes on a known ETL schedule.
These figures aggregate the public records we hold for this employer, primarily WARN Act layoff notices filed with state labor agencies and related US Department of Labor disclosures, and reflect only what employers are legally required to report. Smaller workforce reductions, voluntary separations, and cuts at sites below the federal WARN threshold (generally 100 or more employees, with 50 or more affected) may never appear here. A record's presence is not a verdict on an employer's overall health or conduct; larger employers naturally generate more filings in absolute terms. For hiring, investment, or relocation decisions, read the underlying notices, check the filing dates, and cross-reference the employer's own statements alongside the source links and methodology described below.
How AstraZeneca Pharmaceuticals LP compares to Manufacturing peers
Top H-1B-filing employers in the same NAICS sector. Peer cards link to their own federal-records profile.
AstraZeneca Pharmaceuticals LP
56 H-1B filings
Tesla, Inc.
856 H-1B filings
Intel Corporation
766 H-1B filings
What to check before working with AstraZeneca Pharmaceuticals LP
Read AstraZeneca Pharmaceuticals LP's federal record as three independent signals, pay, safety, and layoff history, not a single rating.
- H-1B median is $175,000 across 56 filings, benchmark any offer against it and the metro prevailing wage. Compare with peers
- No WARN layoff notices on file in our dataset, a positive but not guaranteed stability signal. Reading WARN notices
Every figure is a legally filed public record (DOL, OSHA, state WARN), not a review or vendor estimate; absence of a record is not proof of absence.
Related
Retrieved and formatted by PlainEmployers Editorial.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Learn more: Safety Grades Explained | H-1B Salary Negotiation
Read our methodology - how this data is sourced, computed, and verified.